BAY 60-7550
Names
Preferred IUPAC name
2-[(3,4-Dimethoxyphenyl)methyl]-7-[(2R,3R)-2-hydroxy-6-phenylhexan-3-yl]-5-methylimidazo[5,1-f][1,2,4]triazin-4(1H)-one
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C27H32N4O4/c1-17-25-27(33)29-24(16-20-13-14-22(34-3)23(15-20)35-4)30-31(25)26(28-17)21(18(2)32)12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,18,21,32H,8,11-12,16H2,1-4H3,(H,29,30,33)/t18-,21+/m1/s1
    Key: MYTWFJKBZGMYCS-NQIIRXRSSA-N
  • CC1=C2C(=O)N=C(NN2C(=N1)[C@@H](CCCC3=CC=CC=C3)[C@@H](C)O)CC4=CC(=C(C=C4)OC)OC
Properties
C27H32N4O4
Molar mass 476.577 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

BAY 60-7550 is a type 2 phosphodiesterase inhibitor.[1]

References

  1. ^ Van Donkelaar, EL; Prickaerts, J; Akkerman, S; Rutten, K; Steinbusch, HW; Blokland, A (2013). "No effect of acute tryptophan depletion on phosphodiesterase inhibition--related improvements of short-term object memory in male Wistar rats". Acta Psychiatrica Scandinavica. 128 (2): 107–13. doi:10.1111/acps.12166. PMID 23772681. S2CID 19169985.
Categories